Avadel Pharmaceuticals plc
AVDL
|
|
| |
|
| Trading Volume | 452,775 |
|
|
17.22 - 9.64 |
| Market Cap Full | $ 1.5B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | 19.6% | 27.9% | -15.5% |
| Q2 | - | -1.5% | 79.9% | -64.3% |
| Q3 | - | - | -37.5% | 105.3% |
| Q4 | - | - | 42.2% | 42.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 1.9 | -11.2 | 32.2 | -2.8 | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 5.1 | 32.2 | -7.9 | 14.4 | 32.2 | 19 | -14.4 | -4.2 | -23.8 | -4.3 | 17 | 22.4 |
| 2022 | |||||||||||
| -25.5 | 33.9 | -15.3 | -26.8 | -55.8 | 10.4 | 93.9 | 40.4 | -24.6 | 31.5 | 39.2 | -21.9 |
| 2021 | |||||||||||
| 9.3 | 10.1 | 12.9 | -15.1 | -0.3 | -12.5 | 15.5 | 6.7 | 19.7 | -2.1 | -7.3 | -10.2 |
| 2020 | |||||||||||
| -4.2 | 31.3 | -17.4 | 30.7 | -22.2 | - | -3.1 | -6.6 | -31.1 | -0.2 | 42.7 | -7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.5 | -0.5 | -0.2 | -0 |
| Q2 | -0.8 | -1.1 | -0.3 | 0.5 |
| Q3 | -0.4 | -0.3 | -0.4 | -0.2 |
| Q4 | 0 | -0.4 | -0.4 | -0.1 |
| A | -1.72 | -2.3 | -1.3 | 0.1 |